FDA Adverse Event Injury Summary report: N

MIRADRY SYSTEM

MDR report key: 7862605 · Received September 10, 2018

Report

Report Number
3008082710-2018-00092
Event Type
Injury
Date Received
September 10, 2018
Date of Event
May 18, 2018
Report Date
August 20, 2018
Manufacturer
MIRADRY, INC.
Product Code
OUB
UDI-DI
00853419006008
PMA / PMN Number
K131162
Adverse Event
Yes
Report Source
Manufacturer report
Reporter Location
TX, US
Reporter Occupation
003

Narratives

Description of Event or Problem · 0

PATIENT DEVELOPED LEFT AXILLARY ABSCESS ABOUT 12 DAYS POST MIRADRY TREATMENT. PROPHYLACTIC ANTIBIOTICS WERE PRESCRIBED BUT AN INFECTION DEVELOPED, WHICH BECAME AN ABSCESS. THE ABSCESS WAS INCISED AND DRAINED ALONG WITH DRESSING CHANGES. TWO (2) ANTIBIOTICS WERE PRESCRIBED. THE INFECTION RESOLVED BUT RESULTED INTO A WOUND. BACITRACIN (TOPICAL ANTIBIOTIC) AND WOUND CARE WERE PRESCRIBED FOR 2 MONTHS BUT THE WOUND DID NOT HEAL. THE WOUND WAS CLEANED AND CLOSED BY THE TREATING CLINIC. ANOTHER SET OF ANTIBIOTICS WERE PRESCRIBED. UPDATE: BY 3.7 MONTHS POST-TREATMENT, THE CLINIC CONFIRMED THE INFECTION RESOLVED AND SUSPECTED THE SYMPTOMS WERE DUE TO HIDRADENITIS SUPPURATIVA. PATIENT WAS REFERRED TO A DERMATOLOGIST.

Additional Manufacturer Narrative · 1

REVIEW OF LOT HISTORY RECORDS FOR THE INVOLVED DEVICE CONFIRMED MANUFACTURING STEPS AND PROCESSES WERE MET AND FOLLOWED. PRODUCT MET FINAL INSPECTION AND TESTING REQUIREMENTS PRIOR TO SHIPMENT. THE RATE SEEN ((B)(4) WORLDWIDE INCIDENTS OUT OF ESTIMATED (B)(4) PROCEDURES PERFORMED TO DATE) IS APPROXIMATELY (B)(4)% OF THE PROCEDURES AND WITHIN THE ACCEPTABLE RANGE AS IDENTIFIED IN RISK ANALYSIS DOCUMENTATION.

Description of Event or Problem · 1

PATIENT DEVELOPED LEFT AXILLARY ABSCESS ABOUT 12 DAYS POST MIRADRY TREATMENT. PROPHYLACTIC ANTIBIOTICS WERE PRESCRIBED BUT AN INFECTION DEVELOPED, WHICH BECAME AN ABSCESS. THE ABSCESS WAS INCISED AND DRAINED ALONG WITH DRESSING CHANGES. TWO (2) ANTIBIOTICS WERE PRESCRIBED. THE INFECTION RESOLVED BUT RESULTED INTO A WOUND. BACITRACIN (TOPICAL ANTIBIOTIC) AND WOUND CARE WERE PRESCRIBED FOR 2 MONTHS BUT THE WOUND DID NOT HEAL. THE WOUND WAS CLEANED AND CLOSED BY THE TREATING CLINIC. ANOTHER SET OF ANTIBIOTICS WERE PRESCRIBED.

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
702316 MIRADRY SYSTEM MICROWAVE DERMATOLOGIC SYSTEM OUB MIRADRY, INC. MD4000-MC 16H1520 00853419006008

Patients

Seq Age Sex Outcome Treatment
1 Required Intervention